BE ties up with Janssen Pharmaceutica NV for COVID-19 vaccine production
Johnson & Johnson's COVID-19 vaccine candidate (Ad26.COV2.S) is currently in Phase 1/2 a clinical trials, apress release from the city-based vaccine maker said on Thursday.
Johnson & Johnson's COVID-19 vaccine candidate (Ad26.COV2.S) is currently in Phase 1/2 a clinical trials, apress release from the city-based vaccine maker said on Thursday.